• GSK, under pressure to perform, pens $2.2B deal with Alector focused on neuro R&D, Alzheimer's

    2 monthes ago - By Fierce Biotech

    GSK, under pressure to perform, pens $2.2B deal with Alector focused on neuro R&D, Alzheimer's badams
    Fri, 07/02/2021 - 04:18
    Read more ...